WallStreetZenWallStreetZen

NASDAQ: ERNA
Eterna Therapeutics Inc Stock Ownership - Who owns Eterna Therapeutics?

Insider buying vs selling

Have Eterna Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Sandra M. GurrolaVice President of Finance2023-06-21179$2.48
$443.92Sell

1 of 1

ERNA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ERNA insiders and whales buy or sell their stock.

ERNA Shareholders

What type of owners hold Eterna Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fidelity National Financial Inc710.32%38,430,766$86.85MInsider
Jeffrey Alan Berg386.16%20,892,428$47.22MInsider
Trinad Capital Master Fund Ltd164.50%8,900,093$20.11MInsider
Joseph J. Farricielli Jr.124.85%6,754,611$15.27MInsider
Fidelity National Financial Inc 198.11%5,307,911$12.00MInsider
Matthew Angel64.50%3,489,666$7.89MInsider
John D. Halpern54.09%2,926,551$6.61MInsider
Yiannis Monovoukas31.08%1,681,359$3.80MInsider
Nicholas Jason Singer27.04%1,463,036$3.31MInsider
Charles Cherington10.29%556,465$1.26MInsider

1 of 3

ERNA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ERNA0.91%99.09%Net Selling
PPBT1.23%0.00%
ELAB0.15%99.85%
MBRX45.78%54.22%Net Buying
BNOX0.07%0.00%

Eterna Therapeutics Stock Ownership FAQ

Who owns Eterna Therapeutics?

Eterna Therapeutics (NASDAQ: ERNA) is owned by 16.19% institutional shareholders, 1,764.57% Eterna Therapeutics insiders, and 0.00% retail investors. Fidelity National Financial Inc is the largest individual Eterna Therapeutics shareholder, owning 38.43M shares representing 710.32% of the company. Fidelity National Financial Inc's Eterna Therapeutics shares are currently valued at $86.08M.

If you're new to stock investing, here's how to buy Eterna Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.